It is important to note that there is no established link between GLP-1 medicines and breast cancer specifically
Across these studies, weight loss was consistently greater with semaglutide than with placebo, and the weight loss was associated with improvements in cardiometabolic risk factors including blood pressure, waist circumference, lipid profiles, and inflammatory markers
A 2024 analysis found a significant reduction in the risk of suffering a heart attack or stroke for Wegovy patients, even those who didnt lose significant weight
This mechanism involves activating GLP-1 receptors in the brain, which leads to enhanced feelings of fullness and a reduced desire to eat, effectively aiding in appetite suppression
The ideal candidate is not simply someone who wants to be lighter
Contract development and manufacturing organizations (CDMOs) have rapidly expanded peptide synthesis capabilities to capture the GLP-1 opportunity